De-Risking Life Science Ventures: What Investors Expect Before You Go Global
Gain a clear, investor-level understanding of how to de-risk your life science venture, avoid common funding pitfalls, and strengthen your chances of raising capital and scaling globally. This webinar cuts through the noise and focuses on how investors assess risk - and why many early-stage ventures fail to meet those expectations.
The session explores the key factors investors consistently look for, including clear proof of a real unmet need, a differentiated solution with strong value, a focused market entry strategy, and a credible funding ask linked to concrete milestones. It also sheds light on the most common reasons investors say “no,” helping founders recognize and address critical gaps early on.
Join this webinar to gain a clearer investor perspective, strengthen your de-risking strategy, and better prepare your life science venture for global growth.
Participants have the option to:
check eligibility to German Accelerator programs
Apply to our U.S. Market Access Life Sciences program
The links will be shared after the event.
About the Speakers:
Marc Filerman, CBO The Americas, Start2 Group
Andreas Schumacher, CEO & Co-Founder of Vivalyx
Oliver Uecke, COO Lipotype GmbH and CEO Lipotype Inc.
About the Hosting Company:
German Accelerator offers tailored programs to help German startups expand into international markets by providing access to global markets, expert mentorship, and valuable industry connections.
Our programs fast-track your global growth in 4 months with guidance, key partnerships, and a powerful network. As a result, you save time, money, and avoid costly mistakes - unlike doing it on your own. Fully funded, no equity taken.
This program is made possible in cooperation with the BMWE (Federal Ministry for Economic Affairs and Energy) and is available free of charge for startup development.